Evotec conducts drug discovery, research and development activities with partners such as academic institutions and pharmaceutical and biotech companies. It operates laboratories in five European countries and the United States, and has built a portfolio of more than 200 proprietary and co-owned R&D projects.
Sectors
- News & Analysis
Evotec
Nov 17, 2023 • GCV reporters
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.EventsWebinar: Collaborating with startups - CVC 'platforms' or 'venture client' programs?Aug 14, 2024
OnlineEventsGCV Connect: New Nordics 2024Sep 16 -
Sep 17, 2024
Helsinki (Finland) & Tallinn (Estonia)EventsGCV Institute: CVC Investment ProgramsSep 24 -
Sep 25, 2024
OnlineEventsGCV Institute: Landing the Value of Corporate VenturingOct 18 -
Oct 21, 2024
OnlineEventsGCV Executive Leadership Forum 2024Oct 24, 2024
Menlo Park, CA (USA)EventsCorporate Venture in Brasil 2024 – International Delegation to BrazilOct 28 -
Oct 30, 2024
São Paulo (Brazil)EventsGCV Connect: Germany 2024Oct 29, 2024
Frankfurt (Germany)EventsGCV Asia Congress & International Delegation 2024Nov 11 -
Nov 14, 2024
Tokyo (Japan)EventsGCVI Summit 2025Mar 18 -
Mar 20, 2025
Monterey, CA (USA)Top News
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
© 2024 Mawsonia Ltd. All rights reserved.test regLogin